Email
IZ Express #1,851: Immunize.org adds professional medical society guidance to website, CDC adopts HepB birth dose recommendation, and more
| From | immunize.org <[email protected]> |
| Subject | IZ Express #1,851: Immunize.org adds professional medical society guidance to website, CDC adopts HepB birth dose recommendation, and more |
| Date | January 7, 2026 11:00 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed] [link removed] [link removed] [link removed]
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,851: January 7, 2026
Top Stories
* New! Immunize.org adds vaccine schedules and searchable database of recommendations published by healthcare professional organizations. (#IZX1)
* CDC adopts individual decision-making for HepB vaccination of infants born to women who test negative for the virus (#IZX2)
* Measles: 2025 ends with 2,065 confirmed cases and ongoing outbreaks in three states (#IZX3)
* Respiratory viral activity rises sharply across the country; vaccination reduces risk of severe illness (#IZX4)
* Immunize.org updates “Standing Orders for Administering Meningococcal B Vaccine (MenB) to Adolescents and Adults” (#IZX5)
* Immunize.org updates parent handout, “Top Ten Reasons to Protect Your Child by Vaccinating” (#IZX6)
* Immunize.org updates “Don't Be Guilty of These Preventable Errors in Vaccine Administration!” (#IZX7)
* Immunize.org updates “Questions and Answers” resource on varicella (#IZX8)
* “Influenza Vaccination and Egg Allergy”: watch the 2-minute video, part of the Ask the Experts Video Series on YouTube (#IZX9)
* Vaccines in the news (#IZX10)
Immunize.org Website and Clinical Resources
* Spotlight on the website: View the Calendar of Events (#IZX11)
* Summary: Updated Immunize.org clinical resources, web pages, webinars, and videos released in November and December (#IZX12)
Featured Resources
* “Measles” published by New England Journal of Medicine in its Double Take Video Series (#IZX13)
* Vaccinate Your Family launches minicourse on effective communication and digital resources about mRNA vaccines for healthcare providers (#IZX14)
* Post-Acute and Long-Term Care Medical Association releases two online, self-paced courses, “How to Talk About RSV” and “How to Talk to Staff About Vaccines in the Pipeline for Older Adults.” CME credit offered. (#IZX15)
* Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults (#IZX16)
* Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations (#IZX17)
Notable Publications
* "Detection of Community Transmission of Clade Ib Mpox Virus in the United States” published in "Public Health Alerts" (#IZX18)
Upcoming Events
* Today! Register for Immunize.org Website Office Hours. Join a 30-minute discussion about our Vaccines A–Z content today, January 7 at 4:00 p.m. (ET) or tomorrow, January 8 at 12:00 p.m. (ET). Recorded sessions archived. (#IZX19)
Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
New! Immunize.org adds vaccine schedules and searchable database of recommendations published by healthcare professional organizations.
Some healthcare professional organizations issue evidence-based vaccination guidance for their patient populations. They include the American Academy of Pediatrics (AAP), the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Family Practitioners (AAFP), and others. To better support vaccination providers and educators who rely on our resources, at the end of December 2025 Immunize.org launched two new pages to connect with healthcare professional organization guidance in the new Healthcare Professional Organizations ([link removed]) section on our website.
In this section, you will find links to:
* Healthcare Professional Organization Recommended Schedules ([link removed]) : this web page displays current immunization schedules published by healthcare professional organizations for their patient populations
* Healthcare Professional Organization Vaccine Recommendations ([link removed]) searchable database sorted into two tabs:
+ Comprehensive Recommendations ([link removed]) : this tab lists broad recommendations for a specific population, such as those who are immunocompromised
+ Vaccine-Specific Recommendations ([link removed]) : this web page displays a searchable listing of recommendations published by healthcare professional organizations for the population they serve
[link removed]
These new pages are intended to help you make well-informed clinical decisions about vaccination by offering easy access to evidence-based clinical guidance. Visit Immunize.org's Healthcare Professional Organizations ([link removed]) to view these two new web pages.
Back to top (#Top)
------------------------------------------------------------
CDC adopts individual decision-making for HepB vaccination of infants born to women who test negative for the virus
On December 16, CDC adopted ACIP’s December 5 recommendations as its guidance ([link removed]) on HepB vaccination of infants born to mothers who test negative for the hepatitis B virus (HBV). CDC now recommends individual-based ([link removed]) decision-making ([link removed]) (also known as shared clinical decision-making, or SCDM) for parents deciding whether to give HepB vaccination, including the birth dose, to infants born to mothers who test negative for HBV. For infants born to mothers who test positive for HBV or whose status is unknown, CDC continues its long-standing recommendation to give HepB vaccination and hepatitis B immunoglobulin (HBIG) at birth as post-exposure
prophylaxis. For infants who did not receive the birth dose, CDC recommends the initial dose be administered no earlier than age 2 months.
No new evidence presented to ACIP changed the longstanding balance of risks and benefits of infant HepB vaccination and prevention of HBV infection in any infant, meaning that this balance continues to clearly favor vaccination as early as feasible in light of the high risk of lifelong infection resulting from exposure to HBV during infancy. Mother-to-child exposure represents only one potential source of infant infection.
CDC’s public statement accepting this recommendation also noted that it is still reviewing ACIP's secondary recommendation that parents consult with their healthcare provider about the possibility of serologic testing of infants before completing the recommended HepB series. Therefore, this ACIP recommendation is not an official CDC recommendation.
All federal and private insurance programs will continue to offer HepB vaccination with no out-of-pocket expense for all families. This includes entitlement programs such as the Vaccines for Children Program (VFC), the Children’s Health Insurance Program (CHIP), Medicaid, Medicare, and insurance plans through the federal Health Insurance Marketplace.
The American Academy of Pediatrics (AAP) published a statement ([link removed]) affirming its longstanding recommendation to maintain universal hepatitis B vaccination of all infants, beginning with a birth dose administered within 24 hours of life, as shown on the AAP immunization schedule ([link removed]*4mspnu*_ga*MTEzNDA4OTkxMi4xNzY3NDY0MTg0*_ga_FD9D3XZVQQ*czE3Njc0NjQxODQkbzEkZzEkdDE3Njc0NjQyMDMkajQxJGwwJGgw) .
Related Links
* HHS: CDC Adopts Individual-Based Decision-Making for Hepatitis B Immunization for Infants Born to Women Who Test Negative for the Hepatitis B Virus ([link removed]) (12/16/25)
* Immunize.org: Vaccines A–Z: Hepatitis B ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Measles: 2025 ends with 2,065 confirmed cases and ongoing outbreaks in three states
As of December 31, CDC reported 2,065 confirmed measles cases ([link removed]) in 2025 in 43 states, with Connecticut reporting its first case. Of reported confirmed cases, 88% were outbreak-associated.
* As of January 2, South Carolina reported 188 confirmed cases ([link removed]) , with 185 linked to an ongoing upstate outbreak
* As of December 30, Utah reported 156 confirmed cases ([link removed]) , most related to the outbreak along its border with Arizona
* As of December 13, Arizona reported 205 confirmed cases ([link removed]) , most related to the outbreak along its border with Utah
CDC only requires reporting of laboratory-confirmed measles cases. Cases without laboratory testing for confirmation are not included in these numbers. Actual numbers of cases are, therefore, higher than confirmed case counts.
In November, the Region of the Americas, previously the only region in the world to achieve measles elimination, lost its measles elimination status ([link removed]) because Canada lost its elimination status. Ongoing measles outbreaks in the United States that have persisted for close to a year now place the country at risk of losing its elimination status in early 2026 (officially achieved in 2000). Mexico is also on track to lose its measles elimination status.
The HistoryofVaccines.org ([link removed]) website, produced by the College of Physicians of Philadelphia, published a blog post on November 10 ([link removed]) with a thorough explanation of how measles elimination status is determined, lost, and can be re-established.
A map of 2025 measles cases ([link removed]) in the United States, as of December 31, from the Johns Hopkins International Vaccine Access Center ([link removed]) , appears below. Their U.S. Measles Tracker ([link removed]) website includes state and county-level data.
[link removed]
Immunize.org offers measles-related resources for the public on several of our affiliated websites:
* VaccineInformation.org: Measles ([link removed]) web page
* LetsGetRealAboutVaccines.org: Measles ([link removed]) web page
* Immunize.org: Vaccines A–Z: Measles ([link removed]) main page
Related Links
* AAP: Fact Checked: The Measles Vaccine Is Safe and Effective ([link removed]) web page
* CDC: Measles Cases and Outbreaks ([link removed]) main page
* CDC: Be Ready for Measles toolkit ([link removed])
* Health Canada: Measles and Rubella Weekly Monitoring Report ([link removed])
* Johns Hopkins Bloomberg School of Public Health Center for Outbreak Response Innovation: Measles Outbreak Response ([link removed]) main page
* Immunize.org: Vaccines A–Z: Measles ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Respiratory viral activity rises sharply across the country; vaccination reduces risk of severe illness
An epidemic spike in influenza activity is driving the overall increase in respiratory virus activity reported nationwide. Getting vaccinated now can help reduce the risk of severe illness, complications, and hospitalization.
Nationally, for the week ending December 20 ([link removed]) :
* Seasonal influenza activity increased sharply across the country, with high or very high influenza-like illness (ILI) reported in 32 jurisdictions ([link removed])
* There were 5 influenza-associated deaths reported during week 51 ([link removed]) , for a total of 8 reported ([link removed]) pediatric influenza deaths so far this season
* RSV activity is elevated in many areas of the county
* COVID-19 activity is increasing from low levels
This season’s dominant influenza strain, a subtype A/H3N2 virus referred to as subclade K, is antigenically drifted from the A/H3N2 virus selected for the vaccine. Early reports from England indicate that vaccination remains an effective tool protecting against hospitalization (70%–75% reduced risk in children, 30%–40% reduced risk in adults).
Level of Respiratory Illness Activity
CDC monitors respiratory illness activity using an acute respiratory illness (ARI) metric. The ARI metric measures emergency department visits for a wide range of causes of acute respiratory illness, with or without fever, including the common cold, as well as influenza, RSV, and COVID-19. It offers a more complete picture than the influenza-like illness (ILI) metric used in past seasons. However, for the week ending December 20, because the level of ILI is driving the burden of ARI, the CDC ILI map is displayed below.
[link removed]
Emergency Department Visits for Viral Respiratory Illness
The illustration below shows the proportion of emergency department visits (ranging from 0 to 10 percent) associated with COVID-19, influenza, and RSV. The horizontal axis shows trends from October 2024 into December 2025 for the three diseases, including the sharp increase in influenza-related visits.
[link removed]
Other CDC Respiratory Illness Resources
* CDC's Respiratory Illness Data Channel ([link removed]) shows state and county level data on respiratory viral activity, associated ED visits, and presence in wastewater.
* CDC's Weekly Flu Vaccination Dashboard ([link removed]) shows vaccination rates by age group. Examples include:
+ Adults 18+ Flu Vaccination Coverage ([link removed]) figures show that as of December 6, 129.8 million doses of flu vaccine have been distributed in the United States compared to 142.9 million doses at this same time last year
+ Adults 18+ Flu Vaccinations Administered (IQVIA) ([link removed]) figures show that as of November 29, an estimated 30.9 million doses of flu vaccine were administered in community pharmacies (about 2.1 million fewer than by this time last year) and an estimated 16.7 million doses were administered in physicians' medical offices (about 0.9 million fewer than by this time point last year)
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: RESP-NET ([link removed]) main page
* CDC: FluVaxView ([link removed]) main page
* 65+ Flu Defense ([link removed]) website
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates “Standing Orders for Administering Meningococcal B Vaccine (MenB) to Adolescents and Adults”
Immunize.org updated its Standing Orders for Administering Meningococcal B Vaccine (MenB) to Adolescents and Adults ([link removed]) to note the option to use pentavalent MenABCWY vaccine if a patient age 10 years or older needs both MenB and MenACWY vaccines in the same visit.
[link removed]
Related Links
* Immunize.org: Clinical Resources: Standing Orders Templates ([link removed]) main page
* Immunize.org: Vaccines A–Z: Meningococcal ACWY ([link removed]) main page
* Immunize.org: Vaccines A–Z: Meningococcal B ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates parent handout, “Top Ten Reasons to Protect Your Child by Vaccinating”
Immunize.org updated its parent handout, Top Ten Reasons to Protect Your Child by Vaccinating ([link removed]) . Changes include adding RSV protection in item 3 and making minor wording adjustments.
[link removed]
Related Links
* Immunize.org: Clinical Resources: Parent Handouts ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates “Don't Be Guilty of These Preventable Errors in Vaccine Administration!”
Immunize.org reviewed Don't Be Guilty of These Preventable Errors in Vaccine Administration! ([link removed] ) to incorporate updated CDC MMRV vaccine recommendations limiting its use to children ages 4 years or older. It also incorporates minor changes to improve wording.
[link removed]
Related Links
* Immunize.org: Clinical Resources: Administering Vaccines ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates “Questions and Answers” resource on varicella
Immunize.org updated Varicella (Chickenpox): Questions and Answers ([link removed] ) resource for patients and caregivers to incorporate updated MMRV vaccine recommendations on page three, which now states:
In the several years following the licensure of the combined measles-mumps-rubella (MMR) and varicella vaccines in 2005, surveillance of side effects showed that children who got their first dose as the combined product (MMRV) had more fevers and fever-related seizures (about 1 in 1,250) than children who got the first dose as separate shots of MMR and varicella on the same day. As a result, CDC preferred use of separate MMR and varicella vaccines for the first dose in the 2-dose series. In June of 2025, CDC recommended use of separate MMR and varicella vaccines for all doses given before age 4 years, although no increased risk of febrile seizures has been detected when using MMRV as a second dose in the series. The use of combination vaccine (MMRV) remains generally preferred over separate injections for children who are receiving their second dose or their first dose when age 4 through 12 years.
[link removed]
Related Links
* Immunize.org: Vaccines A–Z: Varicella (Chickenpox) ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
“Influenza Vaccination and Egg Allergy”: watch the 2-minute video, part of the Ask the Experts Video Series on YouTube
This week, our featured episode from the Ask the Experts Video Series is Influenza Vaccination and Egg Allergy ([link removed] ) . The video briefly explains the 2023 ACIP recommendation that people with egg allergy alone do not need any additional safety measures for influenza vaccination beyond those recommended for any other recipient of any vaccine.
The 2-minute video is available on our YouTube channel ([link removed]) , along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
[link removed]
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
Back to top (#Top)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* STAT: Federal Health Officials Slash Recommended Childhood Vaccinations Under Trump’s Directive ([link removed]) (1/5/26)
* Washington Post: U.S. Vaccination Rates Are Plunging. Look Up Where Your School Stands. ([link removed]) (12/31/25)
* NBC: Flu Is Surging Nationwide, and Doctors Say We’re Nowhere Near the Peak ([link removed]) (12/30/25)
* Medpage Today: Vaccine Injury Advisors' Meeting May Portend a Contentious 2026 ([link removed]) (12/29/25)
* NPR: Should the U.S. Model Its Vaccine Policy on Denmark’s? Experts Say We’re Nothing Alike ([link removed]) (12/26/25)
* NBC: As Tetanus Vaccination Rates Decline, Doctors Worry About Rising Case Numbers ([link removed]) (12/24/25)
Back to top (#Top)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Spotlight on the website: View the Calendar of Events
The Immunize.org Calendar of Events ([link removed]) lists upcoming vaccination-related events of national or regional importance, including conferences and ACIP meetings.
From the Immunize.org home page: Scroll to the bottom of the page, where you see “Upcoming Events.” See more details by selecting the More information button for any event. Click the See all Events navy rectangle to view all scheduled calendar dates. Here is the view via computer:
Another way to access calendar events is via the “News & Updates” menu, available at the top of each web page. On the left side, click on “Calendar of Events.” Here is the computer view:
With a mobile device, you can scroll to the bottom of Immunize.org to “Upcoming Events,” but it is faster to access by tapping the hamburger menu (three horizontal lines) on the top right, then tap “News & Updates,” and then tap “Calendar of Events,” as shown in these images:
Vaccination education events on this calendar include those lasting at least half a day that are not restricted to a specific state or local area. Suggest other events by submitting a suggestion through our Contact Us ([link removed]) form on our website.
Back to top (#Top)
------------------------------------------------------------
Summary: Updated Immunize.org clinical resources, web pages, webinars, and videos released in November and December
IZ Express regularly provides readers with information about Immunize.org’s new and updated educational materials for healthcare professionals, as well as patient handouts. All Immunize.org materials are free to distribute.
In case you missed them during recent weeks, the following updated materials were posted for clinicians:
New! Three standing orders for administering:
* 2025–2026 Formula mRNA COVID-19 Vaccine to Children 6 Months through 11 Years ([link removed])
* 2025–2026 Formula mRNA COVID-19 Vaccine to Individuals 12 Years and Older ([link removed])
* 2025–2026 Formula Adjuvanted Protein COVID-19 Vaccine to Individuals 12 Years and Older ([link removed])
Other materials to support immunization and administration:
* Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed])
* Key Vaccination Resources for Healthcare Professionals ([link removed])
* QR Code Links to:
+ New! Spanish Translations of Vaccine Information Statements (VISs) ([link removed])
+ Routinely Recommended Vaccine Information Statements (VISs) ([link removed])
+ All Vaccine Information Statements (VISs) ([link removed])
+ Vaccine Information Statement (VIS) Translations: Influenza (Flu) Vaccine (Inactivated or Recombinant) ([link removed])
* Screening Checklist for Contraindications to HPV, MenACWY, MenB, and Tdap Vaccines for Teens ([link removed]) (Spanish ([link removed]) translation)
Information and immunization schedules to share with patients:
* Vaccines Work! ([link removed])
* Vaccines are Safe: Explaining Why ([link removed])
* What If You Don’t Vaccinate Your Child? ([link removed])
* Measles: Questions and Answers ([link removed])
* Mumps: Questions and Answers ([link removed])
* Rubella: Questions and Answers ([link removed])
* Meningococcal: Questions and Answers ([link removed])
Website Office Hours webinars and training videos:
* Website Office Hours: Travel Vaccines ([link removed]) (28:18)
* Website Office Hours: Image Library, Webinars, Videos, and Social Media ([link removed]) (25:31)
* Website Training Videos: Travel Vaccines ([link removed]) (15:47)
* Website Training Videos: Image Library, Webinars, Videos, and Social Media ([link removed]) (18:00)
Related Links
* Website Office Hours: Clinical Resources ([link removed]) webinar (37:48)
* Orientation Video Series: Introducing Clinical Resources ([link removed]) video (3:37)
* Orientation Video Series: Introducing Clinical Resources [Mobile View] ([link removed]) video (3:29)
Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
“Measles” published by New England Journal of Medicine in its Double Take Video Series
In a Double Take video ([link removed]) (17:35 minutes) from the New England Journal of Medicine, Abarna Pearl, MD, and Lindsey R. Baden, MD, show the presentation and complications of measles, how the disease is diagnosed and managed, and the role of measles vaccination. The discussion also addresses vaccine hesitancy and the limitations of vitamin A in measles care.
[link removed]
Back to top (#Top)
------------------------------------------------------------
Vaccinate Your Family launches minicourse on effective communication and digital resources about mRNA vaccines for healthcare providers
Vaccinate Your Family launched two new free educational resources designed for healthcare providers and available to the public:
* Effective Vaccine Conversations: The Presumptive Recommendation Approach ([link removed]) : A minicourse that provides learners with proven strategies to make vaccine conversations routine, effective, and empathetic. Through real-world examples and interactive practice, participants gain the tools and confidence needed to foster vaccine confidence.
* Understanding mRNA Vaccines: From Development to Immune Response ([link removed]) : A digital download comprised of three PDF resources helps readers communicate confidently and accurately about mRNA vaccine technology and safety.
[link removed]
Back to top (#Top)
------------------------------------------------------------
Post-Acute and Long-Term Care Medical Association releases two online, self-paced courses, “How to Talk About RSV” and “How to Talk to Staff About Vaccines in the Pipeline for Older Adults.” CME credit offered.
The Post-Acute and Long-Term Care Medical Association (PALTmed) released two online, self-paced, interactive courses:
* How to Talk About RSV in PALTC ([link removed]) : This course provides current data regarding RSV vaccination and communication strategies to inform and recommend immunization to post-acute and long-term care (PALTC) residents and their families. It is designed for medical directors, attending physicians, nurse practitioners (NPs), and physician assistants (PAs).
* How to Talk About Vaccines in the Pipeline for Older Adults ([link removed]) : This course provides an overview of vaccine development and vaccines in development that may be available to PALTC residents soon. It is designed for medical directors, attending physicians, NPs, and PAs. Topics include:
+ Overview of the Vaccine Development Process
+ Pneumococcus: Improving a Vaccine
+ Norovirus: Using a New Route of Administration and Platform Technology
+ Clostridioides difficile: Regrouping After a Candidate Vaccine Failure
+ Vaccine Communications Approach
+ Public Health and Vaccine Infrastructure
+ Wrap-Up and Resources
Each course offers CME credit.
Related resources, downloadable tools, and templates are available at movingneedles.org.
Back to top (#Top)
------------------------------------------------------------
Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
Confident healthcare provider recommendations for influenza vaccine are powerfully persuasive. As the nation faces a challenging influenza season, Immunize.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense ([link removed]) website to help you maximize patient protection.
[link removed]
This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the burden and severity of influenza. Resources include:
* Influenza in Adults 65+: The Facts ([link removed])
* Influenza Vaccination: Questions Patients Aged 65 and Older Frequently Ask Their HCP ([link removed])
* The Importance of Preventing Influenza and COVID-19 ([link removed])
Older adults are at increased risk of severe influenza, COVID-19, and RSV illness, including hospitalization and death, especially if they are not up to date on these vaccinations. A clinician recommendation is the most important reason why a person will get vaccinated.
Check out the updated 65+ Flu Defense ([link removed]) website to assist your ongoing efforts in protecting this vulnerable population.
Back to top (#Top)
------------------------------------------------------------
Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations
Immunize.org's www.Give2MenACWY.org ([link removed]) website promotes the importance of adolescent vaccination, including the recommended MenACWY vaccine booster dose at age 16. Many teens are behind on vaccines, so vaccine outreach is more important than ever.
If you are looking for tools to explain meningococcal vaccine recommendations and assist in improving adolescent coverage for all recommended vaccines, view this site. Check out the many helpful tools from Immunize.org, CDC, and other organizations.
[link removed]
The website is divided into five easy-to-access sections:
* Vaccinate Teens ([link removed]) : teen vaccination schedules and tips for improving vaccination rates
* Give 2 Doses ([link removed]) : tools to help improve second dose coverage of MenACWY vaccine
* 16-Year-Old Visit ([link removed]) : resources to help providers and patients remember the important vaccines recommended for 16-year-olds
* Tools for Providers ([link removed]) : tools to explain meningococcal ACWY vaccine recommendations and improve coverage for all adolescent vaccines
* Resources ([link removed]) : links to print materials ([link removed]) , organizations ([link removed]) involved in adolescent vaccination, personal stories ([link removed]) about the importance of vaccination, and other resources ([link removed]) of interest
The site also categorizes materials ([link removed]) according to whether they are primarily of interest to providers, to adolescents, or to parents.
Visit Give2MenACWY.org ([link removed]) and enjoy browsing (and deploying) its bountiful resources.
Related Links
* MenACWY: You're Not Done If You Give Just One: Give 2 Doses to Strengthen Protection ([link removed])
* Recommending MenACWY: What to Say and How to Say It ([link removed])
* Top 10 Ways to Improve Adolescent Immunization Rates ([link removed])
* Developing an Immunization Culture in Your Office ([link removed])
* Know Your Rates: Measuring Immunization Success in Your Practice ([link removed])
* You're 16: We Recommend These Vaccines for You ([link removed])
* Dear Colleague Letter: 16-Year-Old Patients: Make Sure They Receive Their Annual Well Visit and Vaccinations ([link removed]) , signed by six medical societies
* Ask the Experts: Meningococcal ACWY ([link removed])
* CDC: ACIP Meningococcal Vaccine Recommendations ([link removed])
* CDC: Vaccination Coverage Among Adolescents Aged 13–17 Years—National Immunization Survey–Teen, United States, 2024 ([link removed] )
Back to top (#Top)
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Detection of Community Transmission of Clade Ib Mpox Virus in the United States” published in "Public Health Alerts"
In its December 17 issue, "Public Health Alerts" published Detection of Community Transmission of Clade Ib Mpox Virus in the United States ([link removed]) . The abstract appears below.
A clade Ib mpox virus (MPXV) outbreak in Central and Eastern Africa has led to multiple travel-associated infections. In October 2025, clade Ib MPXV infection was confirmed in three unvaccinated, hospitalized men in California reporting no international travel. Phylogenetic analysis revealed clustering of these three MPXV infections with one recent travel-associated MPXV infection. This report provides evidence for local transmission of clade Ib MPXV in the Americas, occurring among gay, bisexual, and other men who have sex with men and their social networks.
Public Health Alerts ([link removed]) , a new section in the journal NEJM Evidence, developed with the Center for Infectious Disease Research and Policy ([link removed]) (CIDRAP), offers brief, open-access reports. These alerts are designed to quickly inform public health officials, clinicians, and the public about emerging health issues.
Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today! Register for Immunize.org Website Office Hours. Join a 30-minute discussion about our Vaccines A–Z content today, January 7 at 4:00 p.m. (ET) or tomorrow, January 8 at 12:00 p.m. (ET). Recorded sessions archived.
To learn simple tips and tricks for using Immunize.org websites efficiently, please register for our next set of Website Office Hours on Wednesday, January 7, at 4:00 p.m. (ET) ([link removed]) or Thursday, January 8, at 12:00 p.m. (ET) ([link removed]) . The same content will be covered in both sessions.
We will open each 30-minute session with a short, live demonstration on navigating our popular Vaccines A–Z website section. You can submit questions when you register or live on Zoom during the session.
[link removed]
Register today for Immunize.org Website Office Hours (content is the same for both):
* Wednesday, January 7, at 4:00 p.m. (ET) ([link removed])
* Thursday, January 8, at 12:00 p.m. (ET) ([link removed])
The archive of previous Website Office Hours content ([link removed]) is posted at Immunize.org’s "Webinars & Videos" page.
Mark your calendar ([link removed]) for future Immunize.org Website Office Hours.
Back to top (#Top)
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Gr
äbenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer (http:// [link removed])
ISSN: 2771-8085
This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,851: January 7, 2026
Top Stories
* New! Immunize.org adds vaccine schedules and searchable database of recommendations published by healthcare professional organizations. (#IZX1)
* CDC adopts individual decision-making for HepB vaccination of infants born to women who test negative for the virus (#IZX2)
* Measles: 2025 ends with 2,065 confirmed cases and ongoing outbreaks in three states (#IZX3)
* Respiratory viral activity rises sharply across the country; vaccination reduces risk of severe illness (#IZX4)
* Immunize.org updates “Standing Orders for Administering Meningococcal B Vaccine (MenB) to Adolescents and Adults” (#IZX5)
* Immunize.org updates parent handout, “Top Ten Reasons to Protect Your Child by Vaccinating” (#IZX6)
* Immunize.org updates “Don't Be Guilty of These Preventable Errors in Vaccine Administration!” (#IZX7)
* Immunize.org updates “Questions and Answers” resource on varicella (#IZX8)
* “Influenza Vaccination and Egg Allergy”: watch the 2-minute video, part of the Ask the Experts Video Series on YouTube (#IZX9)
* Vaccines in the news (#IZX10)
Immunize.org Website and Clinical Resources
* Spotlight on the website: View the Calendar of Events (#IZX11)
* Summary: Updated Immunize.org clinical resources, web pages, webinars, and videos released in November and December (#IZX12)
Featured Resources
* “Measles” published by New England Journal of Medicine in its Double Take Video Series (#IZX13)
* Vaccinate Your Family launches minicourse on effective communication and digital resources about mRNA vaccines for healthcare providers (#IZX14)
* Post-Acute and Long-Term Care Medical Association releases two online, self-paced courses, “How to Talk About RSV” and “How to Talk to Staff About Vaccines in the Pipeline for Older Adults.” CME credit offered. (#IZX15)
* Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults (#IZX16)
* Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations (#IZX17)
Notable Publications
* "Detection of Community Transmission of Clade Ib Mpox Virus in the United States” published in "Public Health Alerts" (#IZX18)
Upcoming Events
* Today! Register for Immunize.org Website Office Hours. Join a 30-minute discussion about our Vaccines A–Z content today, January 7 at 4:00 p.m. (ET) or tomorrow, January 8 at 12:00 p.m. (ET). Recorded sessions archived. (#IZX19)
Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
New! Immunize.org adds vaccine schedules and searchable database of recommendations published by healthcare professional organizations.
Some healthcare professional organizations issue evidence-based vaccination guidance for their patient populations. They include the American Academy of Pediatrics (AAP), the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Family Practitioners (AAFP), and others. To better support vaccination providers and educators who rely on our resources, at the end of December 2025 Immunize.org launched two new pages to connect with healthcare professional organization guidance in the new Healthcare Professional Organizations ([link removed]) section on our website.
In this section, you will find links to:
* Healthcare Professional Organization Recommended Schedules ([link removed]) : this web page displays current immunization schedules published by healthcare professional organizations for their patient populations
* Healthcare Professional Organization Vaccine Recommendations ([link removed]) searchable database sorted into two tabs:
+ Comprehensive Recommendations ([link removed]) : this tab lists broad recommendations for a specific population, such as those who are immunocompromised
+ Vaccine-Specific Recommendations ([link removed]) : this web page displays a searchable listing of recommendations published by healthcare professional organizations for the population they serve
[link removed]
These new pages are intended to help you make well-informed clinical decisions about vaccination by offering easy access to evidence-based clinical guidance. Visit Immunize.org's Healthcare Professional Organizations ([link removed]) to view these two new web pages.
Back to top (#Top)
------------------------------------------------------------
CDC adopts individual decision-making for HepB vaccination of infants born to women who test negative for the virus
On December 16, CDC adopted ACIP’s December 5 recommendations as its guidance ([link removed]) on HepB vaccination of infants born to mothers who test negative for the hepatitis B virus (HBV). CDC now recommends individual-based ([link removed]) decision-making ([link removed]) (also known as shared clinical decision-making, or SCDM) for parents deciding whether to give HepB vaccination, including the birth dose, to infants born to mothers who test negative for HBV. For infants born to mothers who test positive for HBV or whose status is unknown, CDC continues its long-standing recommendation to give HepB vaccination and hepatitis B immunoglobulin (HBIG) at birth as post-exposure
prophylaxis. For infants who did not receive the birth dose, CDC recommends the initial dose be administered no earlier than age 2 months.
No new evidence presented to ACIP changed the longstanding balance of risks and benefits of infant HepB vaccination and prevention of HBV infection in any infant, meaning that this balance continues to clearly favor vaccination as early as feasible in light of the high risk of lifelong infection resulting from exposure to HBV during infancy. Mother-to-child exposure represents only one potential source of infant infection.
CDC’s public statement accepting this recommendation also noted that it is still reviewing ACIP's secondary recommendation that parents consult with their healthcare provider about the possibility of serologic testing of infants before completing the recommended HepB series. Therefore, this ACIP recommendation is not an official CDC recommendation.
All federal and private insurance programs will continue to offer HepB vaccination with no out-of-pocket expense for all families. This includes entitlement programs such as the Vaccines for Children Program (VFC), the Children’s Health Insurance Program (CHIP), Medicaid, Medicare, and insurance plans through the federal Health Insurance Marketplace.
The American Academy of Pediatrics (AAP) published a statement ([link removed]) affirming its longstanding recommendation to maintain universal hepatitis B vaccination of all infants, beginning with a birth dose administered within 24 hours of life, as shown on the AAP immunization schedule ([link removed]*4mspnu*_ga*MTEzNDA4OTkxMi4xNzY3NDY0MTg0*_ga_FD9D3XZVQQ*czE3Njc0NjQxODQkbzEkZzEkdDE3Njc0NjQyMDMkajQxJGwwJGgw) .
Related Links
* HHS: CDC Adopts Individual-Based Decision-Making for Hepatitis B Immunization for Infants Born to Women Who Test Negative for the Hepatitis B Virus ([link removed]) (12/16/25)
* Immunize.org: Vaccines A–Z: Hepatitis B ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Measles: 2025 ends with 2,065 confirmed cases and ongoing outbreaks in three states
As of December 31, CDC reported 2,065 confirmed measles cases ([link removed]) in 2025 in 43 states, with Connecticut reporting its first case. Of reported confirmed cases, 88% were outbreak-associated.
* As of January 2, South Carolina reported 188 confirmed cases ([link removed]) , with 185 linked to an ongoing upstate outbreak
* As of December 30, Utah reported 156 confirmed cases ([link removed]) , most related to the outbreak along its border with Arizona
* As of December 13, Arizona reported 205 confirmed cases ([link removed]) , most related to the outbreak along its border with Utah
CDC only requires reporting of laboratory-confirmed measles cases. Cases without laboratory testing for confirmation are not included in these numbers. Actual numbers of cases are, therefore, higher than confirmed case counts.
In November, the Region of the Americas, previously the only region in the world to achieve measles elimination, lost its measles elimination status ([link removed]) because Canada lost its elimination status. Ongoing measles outbreaks in the United States that have persisted for close to a year now place the country at risk of losing its elimination status in early 2026 (officially achieved in 2000). Mexico is also on track to lose its measles elimination status.
The HistoryofVaccines.org ([link removed]) website, produced by the College of Physicians of Philadelphia, published a blog post on November 10 ([link removed]) with a thorough explanation of how measles elimination status is determined, lost, and can be re-established.
A map of 2025 measles cases ([link removed]) in the United States, as of December 31, from the Johns Hopkins International Vaccine Access Center ([link removed]) , appears below. Their U.S. Measles Tracker ([link removed]) website includes state and county-level data.
[link removed]
Immunize.org offers measles-related resources for the public on several of our affiliated websites:
* VaccineInformation.org: Measles ([link removed]) web page
* LetsGetRealAboutVaccines.org: Measles ([link removed]) web page
* Immunize.org: Vaccines A–Z: Measles ([link removed]) main page
Related Links
* AAP: Fact Checked: The Measles Vaccine Is Safe and Effective ([link removed]) web page
* CDC: Measles Cases and Outbreaks ([link removed]) main page
* CDC: Be Ready for Measles toolkit ([link removed])
* Health Canada: Measles and Rubella Weekly Monitoring Report ([link removed])
* Johns Hopkins Bloomberg School of Public Health Center for Outbreak Response Innovation: Measles Outbreak Response ([link removed]) main page
* Immunize.org: Vaccines A–Z: Measles ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Respiratory viral activity rises sharply across the country; vaccination reduces risk of severe illness
An epidemic spike in influenza activity is driving the overall increase in respiratory virus activity reported nationwide. Getting vaccinated now can help reduce the risk of severe illness, complications, and hospitalization.
Nationally, for the week ending December 20 ([link removed]) :
* Seasonal influenza activity increased sharply across the country, with high or very high influenza-like illness (ILI) reported in 32 jurisdictions ([link removed])
* There were 5 influenza-associated deaths reported during week 51 ([link removed]) , for a total of 8 reported ([link removed]) pediatric influenza deaths so far this season
* RSV activity is elevated in many areas of the county
* COVID-19 activity is increasing from low levels
This season’s dominant influenza strain, a subtype A/H3N2 virus referred to as subclade K, is antigenically drifted from the A/H3N2 virus selected for the vaccine. Early reports from England indicate that vaccination remains an effective tool protecting against hospitalization (70%–75% reduced risk in children, 30%–40% reduced risk in adults).
Level of Respiratory Illness Activity
CDC monitors respiratory illness activity using an acute respiratory illness (ARI) metric. The ARI metric measures emergency department visits for a wide range of causes of acute respiratory illness, with or without fever, including the common cold, as well as influenza, RSV, and COVID-19. It offers a more complete picture than the influenza-like illness (ILI) metric used in past seasons. However, for the week ending December 20, because the level of ILI is driving the burden of ARI, the CDC ILI map is displayed below.
[link removed]
Emergency Department Visits for Viral Respiratory Illness
The illustration below shows the proportion of emergency department visits (ranging from 0 to 10 percent) associated with COVID-19, influenza, and RSV. The horizontal axis shows trends from October 2024 into December 2025 for the three diseases, including the sharp increase in influenza-related visits.
[link removed]
Other CDC Respiratory Illness Resources
* CDC's Respiratory Illness Data Channel ([link removed]) shows state and county level data on respiratory viral activity, associated ED visits, and presence in wastewater.
* CDC's Weekly Flu Vaccination Dashboard ([link removed]) shows vaccination rates by age group. Examples include:
+ Adults 18+ Flu Vaccination Coverage ([link removed]) figures show that as of December 6, 129.8 million doses of flu vaccine have been distributed in the United States compared to 142.9 million doses at this same time last year
+ Adults 18+ Flu Vaccinations Administered (IQVIA) ([link removed]) figures show that as of November 29, an estimated 30.9 million doses of flu vaccine were administered in community pharmacies (about 2.1 million fewer than by this time last year) and an estimated 16.7 million doses were administered in physicians' medical offices (about 0.9 million fewer than by this time point last year)
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: RESP-NET ([link removed]) main page
* CDC: FluVaxView ([link removed]) main page
* 65+ Flu Defense ([link removed]) website
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates “Standing Orders for Administering Meningococcal B Vaccine (MenB) to Adolescents and Adults”
Immunize.org updated its Standing Orders for Administering Meningococcal B Vaccine (MenB) to Adolescents and Adults ([link removed]) to note the option to use pentavalent MenABCWY vaccine if a patient age 10 years or older needs both MenB and MenACWY vaccines in the same visit.
[link removed]
Related Links
* Immunize.org: Clinical Resources: Standing Orders Templates ([link removed]) main page
* Immunize.org: Vaccines A–Z: Meningococcal ACWY ([link removed]) main page
* Immunize.org: Vaccines A–Z: Meningococcal B ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates parent handout, “Top Ten Reasons to Protect Your Child by Vaccinating”
Immunize.org updated its parent handout, Top Ten Reasons to Protect Your Child by Vaccinating ([link removed]) . Changes include adding RSV protection in item 3 and making minor wording adjustments.
[link removed]
Related Links
* Immunize.org: Clinical Resources: Parent Handouts ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates “Don't Be Guilty of These Preventable Errors in Vaccine Administration!”
Immunize.org reviewed Don't Be Guilty of These Preventable Errors in Vaccine Administration! ([link removed] ) to incorporate updated CDC MMRV vaccine recommendations limiting its use to children ages 4 years or older. It also incorporates minor changes to improve wording.
[link removed]
Related Links
* Immunize.org: Clinical Resources: Administering Vaccines ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates “Questions and Answers” resource on varicella
Immunize.org updated Varicella (Chickenpox): Questions and Answers ([link removed] ) resource for patients and caregivers to incorporate updated MMRV vaccine recommendations on page three, which now states:
In the several years following the licensure of the combined measles-mumps-rubella (MMR) and varicella vaccines in 2005, surveillance of side effects showed that children who got their first dose as the combined product (MMRV) had more fevers and fever-related seizures (about 1 in 1,250) than children who got the first dose as separate shots of MMR and varicella on the same day. As a result, CDC preferred use of separate MMR and varicella vaccines for the first dose in the 2-dose series. In June of 2025, CDC recommended use of separate MMR and varicella vaccines for all doses given before age 4 years, although no increased risk of febrile seizures has been detected when using MMRV as a second dose in the series. The use of combination vaccine (MMRV) remains generally preferred over separate injections for children who are receiving their second dose or their first dose when age 4 through 12 years.
[link removed]
Related Links
* Immunize.org: Vaccines A–Z: Varicella (Chickenpox) ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
“Influenza Vaccination and Egg Allergy”: watch the 2-minute video, part of the Ask the Experts Video Series on YouTube
This week, our featured episode from the Ask the Experts Video Series is Influenza Vaccination and Egg Allergy ([link removed] ) . The video briefly explains the 2023 ACIP recommendation that people with egg allergy alone do not need any additional safety measures for influenza vaccination beyond those recommended for any other recipient of any vaccine.
The 2-minute video is available on our YouTube channel ([link removed]) , along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
[link removed]
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
Back to top (#Top)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* STAT: Federal Health Officials Slash Recommended Childhood Vaccinations Under Trump’s Directive ([link removed]) (1/5/26)
* Washington Post: U.S. Vaccination Rates Are Plunging. Look Up Where Your School Stands. ([link removed]) (12/31/25)
* NBC: Flu Is Surging Nationwide, and Doctors Say We’re Nowhere Near the Peak ([link removed]) (12/30/25)
* Medpage Today: Vaccine Injury Advisors' Meeting May Portend a Contentious 2026 ([link removed]) (12/29/25)
* NPR: Should the U.S. Model Its Vaccine Policy on Denmark’s? Experts Say We’re Nothing Alike ([link removed]) (12/26/25)
* NBC: As Tetanus Vaccination Rates Decline, Doctors Worry About Rising Case Numbers ([link removed]) (12/24/25)
Back to top (#Top)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Spotlight on the website: View the Calendar of Events
The Immunize.org Calendar of Events ([link removed]) lists upcoming vaccination-related events of national or regional importance, including conferences and ACIP meetings.
From the Immunize.org home page: Scroll to the bottom of the page, where you see “Upcoming Events.” See more details by selecting the More information button for any event. Click the See all Events navy rectangle to view all scheduled calendar dates. Here is the view via computer:
Another way to access calendar events is via the “News & Updates” menu, available at the top of each web page. On the left side, click on “Calendar of Events.” Here is the computer view:
With a mobile device, you can scroll to the bottom of Immunize.org to “Upcoming Events,” but it is faster to access by tapping the hamburger menu (three horizontal lines) on the top right, then tap “News & Updates,” and then tap “Calendar of Events,” as shown in these images:
Vaccination education events on this calendar include those lasting at least half a day that are not restricted to a specific state or local area. Suggest other events by submitting a suggestion through our Contact Us ([link removed]) form on our website.
Back to top (#Top)
------------------------------------------------------------
Summary: Updated Immunize.org clinical resources, web pages, webinars, and videos released in November and December
IZ Express regularly provides readers with information about Immunize.org’s new and updated educational materials for healthcare professionals, as well as patient handouts. All Immunize.org materials are free to distribute.
In case you missed them during recent weeks, the following updated materials were posted for clinicians:
New! Three standing orders for administering:
* 2025–2026 Formula mRNA COVID-19 Vaccine to Children 6 Months through 11 Years ([link removed])
* 2025–2026 Formula mRNA COVID-19 Vaccine to Individuals 12 Years and Older ([link removed])
* 2025–2026 Formula Adjuvanted Protein COVID-19 Vaccine to Individuals 12 Years and Older ([link removed])
Other materials to support immunization and administration:
* Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed])
* Key Vaccination Resources for Healthcare Professionals ([link removed])
* QR Code Links to:
+ New! Spanish Translations of Vaccine Information Statements (VISs) ([link removed])
+ Routinely Recommended Vaccine Information Statements (VISs) ([link removed])
+ All Vaccine Information Statements (VISs) ([link removed])
+ Vaccine Information Statement (VIS) Translations: Influenza (Flu) Vaccine (Inactivated or Recombinant) ([link removed])
* Screening Checklist for Contraindications to HPV, MenACWY, MenB, and Tdap Vaccines for Teens ([link removed]) (Spanish ([link removed]) translation)
Information and immunization schedules to share with patients:
* Vaccines Work! ([link removed])
* Vaccines are Safe: Explaining Why ([link removed])
* What If You Don’t Vaccinate Your Child? ([link removed])
* Measles: Questions and Answers ([link removed])
* Mumps: Questions and Answers ([link removed])
* Rubella: Questions and Answers ([link removed])
* Meningococcal: Questions and Answers ([link removed])
Website Office Hours webinars and training videos:
* Website Office Hours: Travel Vaccines ([link removed]) (28:18)
* Website Office Hours: Image Library, Webinars, Videos, and Social Media ([link removed]) (25:31)
* Website Training Videos: Travel Vaccines ([link removed]) (15:47)
* Website Training Videos: Image Library, Webinars, Videos, and Social Media ([link removed]) (18:00)
Related Links
* Website Office Hours: Clinical Resources ([link removed]) webinar (37:48)
* Orientation Video Series: Introducing Clinical Resources ([link removed]) video (3:37)
* Orientation Video Series: Introducing Clinical Resources [Mobile View] ([link removed]) video (3:29)
Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
“Measles” published by New England Journal of Medicine in its Double Take Video Series
In a Double Take video ([link removed]) (17:35 minutes) from the New England Journal of Medicine, Abarna Pearl, MD, and Lindsey R. Baden, MD, show the presentation and complications of measles, how the disease is diagnosed and managed, and the role of measles vaccination. The discussion also addresses vaccine hesitancy and the limitations of vitamin A in measles care.
[link removed]
Back to top (#Top)
------------------------------------------------------------
Vaccinate Your Family launches minicourse on effective communication and digital resources about mRNA vaccines for healthcare providers
Vaccinate Your Family launched two new free educational resources designed for healthcare providers and available to the public:
* Effective Vaccine Conversations: The Presumptive Recommendation Approach ([link removed]) : A minicourse that provides learners with proven strategies to make vaccine conversations routine, effective, and empathetic. Through real-world examples and interactive practice, participants gain the tools and confidence needed to foster vaccine confidence.
* Understanding mRNA Vaccines: From Development to Immune Response ([link removed]) : A digital download comprised of three PDF resources helps readers communicate confidently and accurately about mRNA vaccine technology and safety.
[link removed]
Back to top (#Top)
------------------------------------------------------------
Post-Acute and Long-Term Care Medical Association releases two online, self-paced courses, “How to Talk About RSV” and “How to Talk to Staff About Vaccines in the Pipeline for Older Adults.” CME credit offered.
The Post-Acute and Long-Term Care Medical Association (PALTmed) released two online, self-paced, interactive courses:
* How to Talk About RSV in PALTC ([link removed]) : This course provides current data regarding RSV vaccination and communication strategies to inform and recommend immunization to post-acute and long-term care (PALTC) residents and their families. It is designed for medical directors, attending physicians, nurse practitioners (NPs), and physician assistants (PAs).
* How to Talk About Vaccines in the Pipeline for Older Adults ([link removed]) : This course provides an overview of vaccine development and vaccines in development that may be available to PALTC residents soon. It is designed for medical directors, attending physicians, NPs, and PAs. Topics include:
+ Overview of the Vaccine Development Process
+ Pneumococcus: Improving a Vaccine
+ Norovirus: Using a New Route of Administration and Platform Technology
+ Clostridioides difficile: Regrouping After a Candidate Vaccine Failure
+ Vaccine Communications Approach
+ Public Health and Vaccine Infrastructure
+ Wrap-Up and Resources
Each course offers CME credit.
Related resources, downloadable tools, and templates are available at movingneedles.org.
Back to top (#Top)
------------------------------------------------------------
Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
Confident healthcare provider recommendations for influenza vaccine are powerfully persuasive. As the nation faces a challenging influenza season, Immunize.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense ([link removed]) website to help you maximize patient protection.
[link removed]
This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the burden and severity of influenza. Resources include:
* Influenza in Adults 65+: The Facts ([link removed])
* Influenza Vaccination: Questions Patients Aged 65 and Older Frequently Ask Their HCP ([link removed])
* The Importance of Preventing Influenza and COVID-19 ([link removed])
Older adults are at increased risk of severe influenza, COVID-19, and RSV illness, including hospitalization and death, especially if they are not up to date on these vaccinations. A clinician recommendation is the most important reason why a person will get vaccinated.
Check out the updated 65+ Flu Defense ([link removed]) website to assist your ongoing efforts in protecting this vulnerable population.
Back to top (#Top)
------------------------------------------------------------
Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations
Immunize.org's www.Give2MenACWY.org ([link removed]) website promotes the importance of adolescent vaccination, including the recommended MenACWY vaccine booster dose at age 16. Many teens are behind on vaccines, so vaccine outreach is more important than ever.
If you are looking for tools to explain meningococcal vaccine recommendations and assist in improving adolescent coverage for all recommended vaccines, view this site. Check out the many helpful tools from Immunize.org, CDC, and other organizations.
[link removed]
The website is divided into five easy-to-access sections:
* Vaccinate Teens ([link removed]) : teen vaccination schedules and tips for improving vaccination rates
* Give 2 Doses ([link removed]) : tools to help improve second dose coverage of MenACWY vaccine
* 16-Year-Old Visit ([link removed]) : resources to help providers and patients remember the important vaccines recommended for 16-year-olds
* Tools for Providers ([link removed]) : tools to explain meningococcal ACWY vaccine recommendations and improve coverage for all adolescent vaccines
* Resources ([link removed]) : links to print materials ([link removed]) , organizations ([link removed]) involved in adolescent vaccination, personal stories ([link removed]) about the importance of vaccination, and other resources ([link removed]) of interest
The site also categorizes materials ([link removed]) according to whether they are primarily of interest to providers, to adolescents, or to parents.
Visit Give2MenACWY.org ([link removed]) and enjoy browsing (and deploying) its bountiful resources.
Related Links
* MenACWY: You're Not Done If You Give Just One: Give 2 Doses to Strengthen Protection ([link removed])
* Recommending MenACWY: What to Say and How to Say It ([link removed])
* Top 10 Ways to Improve Adolescent Immunization Rates ([link removed])
* Developing an Immunization Culture in Your Office ([link removed])
* Know Your Rates: Measuring Immunization Success in Your Practice ([link removed])
* You're 16: We Recommend These Vaccines for You ([link removed])
* Dear Colleague Letter: 16-Year-Old Patients: Make Sure They Receive Their Annual Well Visit and Vaccinations ([link removed]) , signed by six medical societies
* Ask the Experts: Meningococcal ACWY ([link removed])
* CDC: ACIP Meningococcal Vaccine Recommendations ([link removed])
* CDC: Vaccination Coverage Among Adolescents Aged 13–17 Years—National Immunization Survey–Teen, United States, 2024 ([link removed] )
Back to top (#Top)
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Detection of Community Transmission of Clade Ib Mpox Virus in the United States” published in "Public Health Alerts"
In its December 17 issue, "Public Health Alerts" published Detection of Community Transmission of Clade Ib Mpox Virus in the United States ([link removed]) . The abstract appears below.
A clade Ib mpox virus (MPXV) outbreak in Central and Eastern Africa has led to multiple travel-associated infections. In October 2025, clade Ib MPXV infection was confirmed in three unvaccinated, hospitalized men in California reporting no international travel. Phylogenetic analysis revealed clustering of these three MPXV infections with one recent travel-associated MPXV infection. This report provides evidence for local transmission of clade Ib MPXV in the Americas, occurring among gay, bisexual, and other men who have sex with men and their social networks.
Public Health Alerts ([link removed]) , a new section in the journal NEJM Evidence, developed with the Center for Infectious Disease Research and Policy ([link removed]) (CIDRAP), offers brief, open-access reports. These alerts are designed to quickly inform public health officials, clinicians, and the public about emerging health issues.
Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today! Register for Immunize.org Website Office Hours. Join a 30-minute discussion about our Vaccines A–Z content today, January 7 at 4:00 p.m. (ET) or tomorrow, January 8 at 12:00 p.m. (ET). Recorded sessions archived.
To learn simple tips and tricks for using Immunize.org websites efficiently, please register for our next set of Website Office Hours on Wednesday, January 7, at 4:00 p.m. (ET) ([link removed]) or Thursday, January 8, at 12:00 p.m. (ET) ([link removed]) . The same content will be covered in both sessions.
We will open each 30-minute session with a short, live demonstration on navigating our popular Vaccines A–Z website section. You can submit questions when you register or live on Zoom during the session.
[link removed]
Register today for Immunize.org Website Office Hours (content is the same for both):
* Wednesday, January 7, at 4:00 p.m. (ET) ([link removed])
* Thursday, January 8, at 12:00 p.m. (ET) ([link removed])
The archive of previous Website Office Hours content ([link removed]) is posted at Immunize.org’s "Webinars & Videos" page.
Mark your calendar ([link removed]) for future Immunize.org Website Office Hours.
Back to top (#Top)
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Gr
äbenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer (http:// [link removed])
ISSN: 2771-8085
This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp